Skip to main content
Erschienen in: Cancer Causes & Control 12/2012

01.12.2012 | Original Paper

Gender- and ethnicity-specific survival trends of oral cavity and oropharyngeal cancers in British Columbia

verfasst von: Ajit Auluck, Greg Hislop, Chris Bajdik, John Hay, Joan L. Bottorff, Lewei Zhang, Miriam P. Rosin

Erschienen in: Cancer Causes & Control | Ausgabe 12/2012

Einloggen, um Zugang zu erhalten

Abstract

Introduction

A shift in etiology of oral cancers has been associated with a rise in incidence for oropharyngeal cancers (OPC) and decrease for oral cavity cancers (OCC); however, there is limited information about population-based survival trends. We report epidemiological transitions in survival for both OPC and OCC from a population-based cancer registry, focusing upon gender and ethnic differences.

Methods

All primary oral cancers diagnosed between 1980 and 2005 were identified from the British Columbia Cancer Registry and regrouped into OPC and OCC by topographical subsites, time periods (1980–1993 and 1994–2005), stage at diagnosis, and ethnicity. Cases were then followed up to December 2009. Using gender-based analysis, actuarial life tables were used to calculate survival rates, which were compared using Kaplan–Meier curves and log-rank tests.

Results

For OPC, survival improved, significant for tonsil and base of tongue in men and marginally significant at base of tongue in women. This improvement occurred in spite of an increase in late-stage diagnosis for OPC in both genders. Interestingly, there was no difference in survival for early- and late-stage disease for OPC in men. For OCC, there was a decrease in survival for floor of mouth cancers in both genders although significant in women only. South Asians had the poorest survival for OCC in both genders.

Conclusion

Survival for OPC improved, more dramatically in men than women, in spite of late-stage diagnosis and increasing nodal involvement. Given the poor survival rates and need for early detection, targeted OCC screening programs are required for South Asians.
Literatur
1.
Zurück zum Zitat Chaturvedi AK, Engels EA, Anderson WF, Gillison ML (2008) Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 26:612–619PubMedCrossRef Chaturvedi AK, Engels EA, Anderson WF, Gillison ML (2008) Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 26:612–619PubMedCrossRef
2.
Zurück zum Zitat Chaturvedi AK, Engels EA, Pfeiffer RM et al (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29(32):4294–4301 Chaturvedi AK, Engels EA, Pfeiffer RM et al (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29(32):4294–4301
3.
Zurück zum Zitat Mork J, Moller B, Dahl T, Bray F (2010) Time trends in pharyngeal cancer incidence in Norway 1981–2005: a subsite analysis based on a reabstraction and recoding of registered cases. Cancer Causes Control 21:1397–1405PubMedCrossRef Mork J, Moller B, Dahl T, Bray F (2010) Time trends in pharyngeal cancer incidence in Norway 1981–2005: a subsite analysis based on a reabstraction and recoding of registered cases. Cancer Causes Control 21:1397–1405PubMedCrossRef
4.
Zurück zum Zitat Hammarstedt L, Lindquist D, Dahlstrand H et al (2006) Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 119:2620–2623PubMedCrossRef Hammarstedt L, Lindquist D, Dahlstrand H et al (2006) Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 119:2620–2623PubMedCrossRef
5.
Zurück zum Zitat Braakhuis BJ, Visser O, Leemans CR (2009) Oral and oropharyngeal cancer in The Netherlands between 1989 and 2006: increasing incidence, but not in young adults. Oral Oncol 45:e85–e89PubMedCrossRef Braakhuis BJ, Visser O, Leemans CR (2009) Oral and oropharyngeal cancer in The Netherlands between 1989 and 2006: increasing incidence, but not in young adults. Oral Oncol 45:e85–e89PubMedCrossRef
6.
7.
Zurück zum Zitat Blomberg M, Nielsen A, Munk C, Kjaer SK (2011) Trends in head and neck cancer incidence in Denmark, 1978–2007: focus on human papillomavirus associated sites. Int J Cancer 129:733–741PubMedCrossRef Blomberg M, Nielsen A, Munk C, Kjaer SK (2011) Trends in head and neck cancer incidence in Denmark, 1978–2007: focus on human papillomavirus associated sites. Int J Cancer 129:733–741PubMedCrossRef
8.
Zurück zum Zitat Hocking JS, Stein A, Conway EL et al (2011) Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers. Br J Cancer 104:886–891PubMedCrossRef Hocking JS, Stein A, Conway EL et al (2011) Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers. Br J Cancer 104:886–891PubMedCrossRef
9.
Zurück zum Zitat Ligier K, Belot A, Launoy G et al (2011) Descriptive epidemiology of upper aerodigestive tract cancers in France: incidence over 1980–2005 and projection to 2010. Oral Oncol 47:302–307PubMedCrossRef Ligier K, Belot A, Launoy G et al (2011) Descriptive epidemiology of upper aerodigestive tract cancers in France: incidence over 1980–2005 and projection to 2010. Oral Oncol 47:302–307PubMedCrossRef
10.
Zurück zum Zitat Guntinas-Lichius O, Wendt T, Buentzel J et al (2010) Head and neck cancer in Germany: a site-specific analysis of survival of the Thuringian cancer registration database. J Cancer Res Clin Oncol 136:55–63PubMedCrossRef Guntinas-Lichius O, Wendt T, Buentzel J et al (2010) Head and neck cancer in Germany: a site-specific analysis of survival of the Thuringian cancer registration database. J Cancer Res Clin Oncol 136:55–63PubMedCrossRef
11.
Zurück zum Zitat Reddy VM, Cundall-Curry D, Bridger MW (2010) Trends in the incidence rates of tonsil and base of tongue cancer in England, 1985–2006. Ann R Coll Surg Engl 92:655–659PubMedCrossRef Reddy VM, Cundall-Curry D, Bridger MW (2010) Trends in the incidence rates of tonsil and base of tongue cancer in England, 1985–2006. Ann R Coll Surg Engl 92:655–659PubMedCrossRef
12.
Zurück zum Zitat de Souza DL, Bernal Perez MM, Curado MP (2011) Predicted incidence of oral cavity, oropharyngeal, laryngeal, and hypopharyngeal cancer in Spain and implications for cancer control. Cancer Epidemiol 35(6):510–514 de Souza DL, Bernal Perez MM, Curado MP (2011) Predicted incidence of oral cavity, oropharyngeal, laryngeal, and hypopharyngeal cancer in Spain and implications for cancer control. Cancer Epidemiol 35(6):510–514
13.
Zurück zum Zitat Brown LM, Check DP, Devesa SS (2011) Oropharyngeal cancer incidence trends: diminishing racial disparities. Cancer Causes Control 22:753–763PubMedCrossRef Brown LM, Check DP, Devesa SS (2011) Oropharyngeal cancer incidence trends: diminishing racial disparities. Cancer Causes Control 22:753–763PubMedCrossRef
14.
Zurück zum Zitat Gupta S, Kong W, Peng Y, Miao Q, Mackillop WJ (2009) Temporal trends in the incidence and survival of cancers of the upper aerodigestive tract in Ontario and the United States. Int J Cancer 125:2159–2165PubMedCrossRef Gupta S, Kong W, Peng Y, Miao Q, Mackillop WJ (2009) Temporal trends in the incidence and survival of cancers of the upper aerodigestive tract in Ontario and the United States. Int J Cancer 125:2159–2165PubMedCrossRef
15.
Zurück zum Zitat Hammarstedt L, Lu Y, Marklund L, Dalianis T, Munck-Wikland E, Ye W (2011) Differential survival trends for patients with tonsillar, base of tongue and tongue cancer in Sweden. Oral Oncol 47:636–641PubMedCrossRef Hammarstedt L, Lu Y, Marklund L, Dalianis T, Munck-Wikland E, Ye W (2011) Differential survival trends for patients with tonsillar, base of tongue and tongue cancer in Sweden. Oral Oncol 47:636–641PubMedCrossRef
16.
Zurück zum Zitat Auluck A, Hislop G, Bajdik C, Poh C, Zhang L, Rosin M (2010) Trends in oropharyngeal and oral cavity cancer incidence of human papillomavirus (HPV)-related and HPV-unrelated sites in a multicultural population: the British Columbia experience. Cancer 116:2635–2644PubMed Auluck A, Hislop G, Bajdik C, Poh C, Zhang L, Rosin M (2010) Trends in oropharyngeal and oral cavity cancer incidence of human papillomavirus (HPV)-related and HPV-unrelated sites in a multicultural population: the British Columbia experience. Cancer 116:2635–2644PubMed
17.
Zurück zum Zitat Patel SG, Shah JP (2005) TNM staging of cancers of the head and neck: striving for uniformity among diversity. CA Cancer J Clin 55:242–258; quiz 61–62, 64PubMedCrossRef Patel SG, Shah JP (2005) TNM staging of cancers of the head and neck: striving for uniformity among diversity. CA Cancer J Clin 55:242–258; quiz 61–62, 64PubMedCrossRef
18.
Zurück zum Zitat Hislop GT, Bajdik CD, Regier MD, Barroetavena MC (2007) Ethnic differences in survival for female cancers of the breast, cervix and colorectum in British Columbia, Canada. Asian Pac J Cancer Prev 8:209–214PubMed Hislop GT, Bajdik CD, Regier MD, Barroetavena MC (2007) Ethnic differences in survival for female cancers of the breast, cervix and colorectum in British Columbia, Canada. Asian Pac J Cancer Prev 8:209–214PubMed
19.
Zurück zum Zitat Chaturvedi AK, Engels EA, Pfeiffer RM et al (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29:4294–4301PubMedCrossRef Chaturvedi AK, Engels EA, Pfeiffer RM et al (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29:4294–4301PubMedCrossRef
20.
Zurück zum Zitat Gillison ML, Broutian T, Pickard RK et al (2012) Prevalence of oral HPV infection in the United States, 2009–2010. JAMA 307:693–703PubMedCrossRef Gillison ML, Broutian T, Pickard RK et al (2012) Prevalence of oral HPV infection in the United States, 2009–2010. JAMA 307:693–703PubMedCrossRef
21.
Zurück zum Zitat Aziz L, Nyman J, Edstrom S (2010) T but not N stage predicts survival for patients with tonsillar carcinoma treated with external radiotherapy and brachytherapy. Acta Oncol 49:821–825PubMedCrossRef Aziz L, Nyman J, Edstrom S (2010) T but not N stage predicts survival for patients with tonsillar carcinoma treated with external radiotherapy and brachytherapy. Acta Oncol 49:821–825PubMedCrossRef
23.
Zurück zum Zitat Liao CT, Kang CJ, Chang JT et al (2007) Survival of second and multiple primary tumors in patients with oral cavity squamous cell carcinoma in the betel quid chewing area. Oral Oncol 43:811–819PubMedCrossRef Liao CT, Kang CJ, Chang JT et al (2007) Survival of second and multiple primary tumors in patients with oral cavity squamous cell carcinoma in the betel quid chewing area. Oral Oncol 43:811–819PubMedCrossRef
24.
Zurück zum Zitat Bajdik CD, Barroetavena MC, Saroa SR, Hislop TG (2008) Agreement between birthplace and self-reported ethnicity in a population-based mammography service. Asian Pac J Cancer Prev 9:511–514PubMed Bajdik CD, Barroetavena MC, Saroa SR, Hislop TG (2008) Agreement between birthplace and self-reported ethnicity in a population-based mammography service. Asian Pac J Cancer Prev 9:511–514PubMed
Metadaten
Titel
Gender- and ethnicity-specific survival trends of oral cavity and oropharyngeal cancers in British Columbia
verfasst von
Ajit Auluck
Greg Hislop
Chris Bajdik
John Hay
Joan L. Bottorff
Lewei Zhang
Miriam P. Rosin
Publikationsdatum
01.12.2012
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 12/2012
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-012-0065-0

Weitere Artikel der Ausgabe 12/2012

Cancer Causes & Control 12/2012 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.